Tearlab Corp (TEAR) 2.15 $TEAR
TearLab Corporation Announces Inducement Grant Under NASDAQ Rule 5635(c)(4)
GlobeNewswire - Fri Feb 06, 6:45AM CST
TearLab Corporation (Nasdaq:TEAR) (TSX:TLB) ("TearLab" or the "Company"
today announced that on February 5, 2015, a majority of the independent members of the Company's Board of Directors approved the grant of an option to purchase 100,000 shares of the Company's common stock to Raymond Kong, the Company's Vice President of Sales. The stock option has a ten-year term and a per share exercise price equal to the higher of (i) the closing price per share of the Company's common stock as quoted on the Nasdaq Capital Market on February 5, 2015 or (ii) the prior five-day volume weighted average price of the Company's common stock as quoted on the Nasdaq Capital Market at the close of business on February 5, 2015. The stock option has a vesting commencement date of February 5, 2015, and will vest in equal annual increments over a three year period, subject to Mr. Kong's continued service with the Company through each applicable vesting date. In addition, the stock option will fully accelerate as to vesting in the event of a change of control prior to Mr. Kong's termination of service. The stock option grant was made as an inducement that was material to Mr. Kong's acceptance of employment with the Company and was granted as an employment inducement award pursuant to NASDAQ Listing Rule 5635(c)(4).
TEAR: 2.15 (+0.03), TLB.TO: 2.64 (unch)
TearLab Corporation (TEAR) Jumps: Stock Rises 7.2% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Jan 28, 8:11AM CST
TearLab Corporation (TEAR) was a big mover last session, as the company saw its shares rise over 7% on the day.
TEAR: 2.15 (+0.03), INGN: 33.53 (+2.32)
TearLab Appoints Raymond Kong as Vice President of Sales
GlobeNewswire - Wed Jan 28, 7:10AM CST
TearLab Corporation (Nasdaq:TEAR) (TSX:TLB) ("TearLab" or the "Company" today announced the appointment of Raymond Kong to its senior management team as Vice President of Sales.
TEAR: 2.15 (+0.03), TLB.TO: 2.64 (unch)
Midday Gainers / Losers
Seeking Alpha - at Seeking Alpha - Mon Jan 26, 11:46AM CST
HTBX: 5.83 (+0.22), NES: 3.52 (+0.13), TEAR: 2.15 (+0.03), FENG: 7.92 (+0.23), OCN: 9.10 (+0.09), STX: 61.83 (+0.67), LACO: 8.38 (+0.17), PHMD: 1.68 (+0.04), BBEP: 7.85 (+0.32), HGSH: 3.05 (-0.13), MBT: 10.36 (+0.62), NBG: 1.61 (+0.18), NDRM: 10.76 (+0.22), PT: 0.83 (+0.04), POST: 48.62 (-0.25), ATNM: 3.60 (-0.29), MWV: 53.91 (+0.59), WRES: 1.27 (+0.01), IDN: 1.43 (-0.01), KONE: 4.20 (+0.03)
Insider Trading Alert - RPTP, TEAR And ISRG Traded By Insiders
at The Street - Wed Nov 26, 10:59AM CST
Stocks with insider trader activity include RPTP, TEAR and ISRG
ISRG: 510.73 (+3.02), TEAR: 2.15 (+0.03), RPTP: 9.05 (-0.40)
TearLab (TEAR) in Focus: Stock Moves 9.1% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Nov 25, 7:30AM CST
TearLab Corporation (TEAR) was a big mover last session, as the company saw its shares rise over 9% on the day.
ETRM: 1.21 (+0.06), TEAR: 2.15 (+0.03), FLDM: 37.93 (-0.47), ANGO: 18.78 (+0.18)
TearLab to Participate in November Investor Conferences
GlobeNewswire - Mon Nov 10, 3:30PM CST
TearLab Corporation (Nasdaq:TEAR) (TSX:TLB) ("TearLab" or the "Company" announced today that it will participate in two investor conferences in November.
TEAR: 2.15 (+0.03), TLB.TO: 2.64 (unch)
TearLab's (TEAR) CEO Elias Vamvakas on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Wed Nov 05, 9:05PM CST
TEAR: 2.15 (+0.03)
TearLab misses by $0.01, misses on revenue
Seeking Alpha - at Seeking Alpha - Wed Nov 05, 4:04PM CST
TEAR: 2.15 (+0.03)
TearLab Corporation Reports Q3-14 Financial Results
GlobeNewswire - Wed Nov 05, 3:37PM CST
TearLab Corporation (Nasdaq:TEAR) (TSX:TLB) ("TearLab" or the "Company" today reported its consolidated financial results for the third quarter ended September 30, 2014. All dollar amounts are expressed in U.S. currency and results are reported in accordance with United States generally accepted accounting principles.
TEAR: 2.15 (+0.03), TLB.TO: 2.64 (unch)
TearLab (TEAR) Q3 2014 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Wed Nov 05, 3:25PM CST
TEAR: 2.15 (+0.03)
TearLab Corporation to Release Q3 2014 Financial Results on November 5, 2014
GlobeNewswire - Wed Oct 22, 3:00PM CDT
TearLab Corporation (Nasdaq:TEAR) (TSX:TLB) ("TearLab" or the "Company" expects to announce its Q3 2014 financial results after market closes on Wednesday November 5, 2014. TearLab is pleased to invite all willing participants in a conference call during which time financial results will be discussed. This call will be held at 4:30pm Eastern at 877-303-1593.
TEAR: 2.15 (+0.03), TLB.TO: 2.64 (unch)
Julie Speed Joins TearLab as Vice President, Global Marketing
GlobeNewswire - Mon Oct 06, 3:15PM CDT
TearLab Corporation (Nasdaq:TEAR) (TSX:TLB) ("TearLab" or the "Company" today announced the appointment of Julie Speed to its senior management team as Vice President, Global Marketing.
TEAR: 2.15 (+0.03), TLB.TO: 2.64 (unch)
TearLab to Participate in BTIG's Inaugural Emerging Technologies in Healthcare Diagnostics Symposium
GlobeNewswire - Thu Sep 25, 3:15PM CDT
TearLab Corporation (Nasdaq:TEAR) (TSX:TLB) ("TearLab" or the "Company" announced today that its Chief Executive Officer, Elias Vamvakas, will participate in the BTIG Emerging Technologies in Healthcare Diagnostics Symposium on Tuesday, September 30, 2014 at the Benjamin Hotel in New York City.
TEAR: 2.15 (+0.03), TLB.TO: 2.64 (unch)
Study Demonstrates Hyperosmolarity of the Ocular Surface May Impact Cataract Surgery Planning
GlobeNewswire - Mon Sep 15, 3:39PM CDT
TearLab Corporation (Nasdaq:TEAR) (TSX:TLB) ("TearLab" or the "Company" announced that preliminary results of the TearLab Cataract Study were presented today at the XXXIII Congress of the European Society of Cataract and Refractive Surgeons ("ESCRS" .
TEAR: 2.15 (+0.03), TLB.TO: 2.64 (unch)
TearLab to Participate in Craig-Hallum's 5th Annual Alpha Select Conference
GlobeNewswire - Thu Sep 11, 7:30AM CDT
TearLab Corporation (Nasdaq:TEAR) (TSX:TLB) ("TearLab" or the "Company" announced today that its Chief Executive Officer, Elias Vamvakas, will present an update on the Company's business at the 5th Annual Craig-Hallum Alpha Select Conference on Thursday, September 18, 2014 at 2:50 p.m. Eastern Time at the Convene Conference Center in New York City.
TEAR: 2.15 (+0.03), TLB.TO: 2.64 (unch)
TearLab Reports Interim Results From Multi-Center DED Prevalence Study in the UK
GlobeNewswire - Thu Sep 04, 7:36AM CDT
TearLab Corporation (Nasdaq:TEAR) (TSX:TLB) ("TearLab" or the "Company" today announced interim results of a multi-center dry eye disease ("DED" prevalence study being carried out in the United Kingdom at four National Health Service ("NHS" hospitals.
TEAR: 2.15 (+0.03), TLB.TO: 2.64 (unch)
TearLab to Host Analyst and Investor Day
GlobeNewswire - Thu Aug 14, 10:59AM CDT
TearLab Corporation (Nasdaq:TEAR) (TSX:TLB) ("TearLab" or the "Company" announced today that it will host an "Analyst and Investor Day" in San Diego, CA on Tuesday, September 23, 2014. The event will be held at the Company's offices at 9980 Huennekens St. from 10:00am to 4:00pm Pacific Time.
TEAR: 2.15 (+0.03), TLB.TO: 2.64 (unch)
TearLab to Participate in the Canaccord Genuity 34th Annual Growth Conference
GlobeNewswire - Mon Aug 11, 7:30AM CDT
TearLab Corporation (Nasdaq:TEAR) (TSX:TLB) ("TearLab" or the "Company" announced today that its President & COO, Seph Jensen, will present an update on the Company's business at the Canaccord Genuity 34th Annual Growth Conference on Thursday, August 14, 2014 at 3:30 p.m. Eastern Time. The conference will be held at the InterContinental Boston Hotel in Boston, MA.
TEAR: 2.15 (+0.03), TLB.TO: 2.64 (unch)
TearLab Corporation Reports Q2-14 Financial Results and Adjusts 2014 Revenue Guidance
GlobeNewswire - Thu Aug 07, 3:43PM CDT
TearLab Corporation (Nasdaq:TEAR) (TSX:TLB) ("TearLab" or the "Company" today reported its consolidated financial results for the second quarter ended June 30, 2014. All dollar amounts are expressed in U.S. currency and results are reported in accordance with United States generally accepted accounting principles.
TEAR: 2.15 (+0.03), TLB.TO: 2.64 (unch)
TearLab Corporation Announces Inducement Grant Under NASDAQ Rule 5635(c)(4)
GlobeNewswire - Fri Feb 06, 6:45AM CST
TearLab Corporation (Nasdaq:TEAR) (TSX:TLB) ("TearLab" or the "Company"
today announced that on February 5, 2015, a majority of the independent members of the Company's Board of Directors approved the grant of an option to purchase 100,000 shares of the Company's common stock to Raymond Kong, the Company's Vice President of Sales. The stock option has a ten-year term and a per share exercise price equal to the higher of (i) the closing price per share of the Company's common stock as quoted on the Nasdaq Capital Market on February 5, 2015 or (ii) the prior five-day volume weighted average price of the Company's common stock as quoted on the Nasdaq Capital Market at the close of business on February 5, 2015. The stock option has a vesting commencement date of February 5, 2015, and will vest in equal annual increments over a three year period, subject to Mr. Kong's continued service with the Company through each applicable vesting date. In addition, the stock option will fully accelerate as to vesting in the event of a change of control prior to Mr. Kong's termination of service. The stock option grant was made as an inducement that was material to Mr. Kong's acceptance of employment with the Company and was granted as an employment inducement award pursuant to NASDAQ Listing Rule 5635(c)(4). TEAR: 2.15 (+0.03), TLB.TO: 2.64 (unch)
TearLab Corporation (TEAR) Jumps: Stock Rises 7.2% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Jan 28, 8:11AM CST
TearLab Corporation (TEAR) was a big mover last session, as the company saw its shares rise over 7% on the day.
TEAR: 2.15 (+0.03), INGN: 33.53 (+2.32)
TearLab Appoints Raymond Kong as Vice President of Sales
GlobeNewswire - Wed Jan 28, 7:10AM CST
TearLab Corporation (Nasdaq:TEAR) (TSX:TLB) ("TearLab" or the "Company"
today announced the appointment of Raymond Kong to its senior management team as Vice President of Sales. TEAR: 2.15 (+0.03), TLB.TO: 2.64 (unch)
Midday Gainers / Losers
Seeking Alpha - at Seeking Alpha - Mon Jan 26, 11:46AM CST
HTBX: 5.83 (+0.22), NES: 3.52 (+0.13), TEAR: 2.15 (+0.03), FENG: 7.92 (+0.23), OCN: 9.10 (+0.09), STX: 61.83 (+0.67), LACO: 8.38 (+0.17), PHMD: 1.68 (+0.04), BBEP: 7.85 (+0.32), HGSH: 3.05 (-0.13), MBT: 10.36 (+0.62), NBG: 1.61 (+0.18), NDRM: 10.76 (+0.22), PT: 0.83 (+0.04), POST: 48.62 (-0.25), ATNM: 3.60 (-0.29), MWV: 53.91 (+0.59), WRES: 1.27 (+0.01), IDN: 1.43 (-0.01), KONE: 4.20 (+0.03)
Insider Trading Alert - RPTP, TEAR And ISRG Traded By Insiders
at The Street - Wed Nov 26, 10:59AM CST
Stocks with insider trader activity include RPTP, TEAR and ISRG
ISRG: 510.73 (+3.02), TEAR: 2.15 (+0.03), RPTP: 9.05 (-0.40)
TearLab (TEAR) in Focus: Stock Moves 9.1% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Nov 25, 7:30AM CST
TearLab Corporation (TEAR) was a big mover last session, as the company saw its shares rise over 9% on the day.
ETRM: 1.21 (+0.06), TEAR: 2.15 (+0.03), FLDM: 37.93 (-0.47), ANGO: 18.78 (+0.18)
TearLab to Participate in November Investor Conferences
GlobeNewswire - Mon Nov 10, 3:30PM CST
TearLab Corporation (Nasdaq:TEAR) (TSX:TLB) ("TearLab" or the "Company"
announced today that it will participate in two investor conferences in November. TEAR: 2.15 (+0.03), TLB.TO: 2.64 (unch)
TearLab's (TEAR) CEO Elias Vamvakas on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Wed Nov 05, 9:05PM CST
TEAR: 2.15 (+0.03)
TearLab misses by $0.01, misses on revenue
Seeking Alpha - at Seeking Alpha - Wed Nov 05, 4:04PM CST
TEAR: 2.15 (+0.03)
TearLab Corporation Reports Q3-14 Financial Results
GlobeNewswire - Wed Nov 05, 3:37PM CST
TearLab Corporation (Nasdaq:TEAR) (TSX:TLB) ("TearLab" or the "Company"
today reported its consolidated financial results for the third quarter ended September 30, 2014. All dollar amounts are expressed in U.S. currency and results are reported in accordance with United States generally accepted accounting principles. TEAR: 2.15 (+0.03), TLB.TO: 2.64 (unch)
TearLab (TEAR) Q3 2014 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Wed Nov 05, 3:25PM CST
TEAR: 2.15 (+0.03)
TearLab Corporation to Release Q3 2014 Financial Results on November 5, 2014
GlobeNewswire - Wed Oct 22, 3:00PM CDT
TearLab Corporation (Nasdaq:TEAR) (TSX:TLB) ("TearLab" or the "Company"
expects to announce its Q3 2014 financial results after market closes on Wednesday November 5, 2014. TearLab is pleased to invite all willing participants in a conference call during which time financial results will be discussed. This call will be held at 4:30pm Eastern at 877-303-1593. TEAR: 2.15 (+0.03), TLB.TO: 2.64 (unch)
Julie Speed Joins TearLab as Vice President, Global Marketing
GlobeNewswire - Mon Oct 06, 3:15PM CDT
TearLab Corporation (Nasdaq:TEAR) (TSX:TLB) ("TearLab" or the "Company"
today announced the appointment of Julie Speed to its senior management team as Vice President, Global Marketing. TEAR: 2.15 (+0.03), TLB.TO: 2.64 (unch)
TearLab to Participate in BTIG's Inaugural Emerging Technologies in Healthcare Diagnostics Symposium
GlobeNewswire - Thu Sep 25, 3:15PM CDT
TearLab Corporation (Nasdaq:TEAR) (TSX:TLB) ("TearLab" or the "Company"
announced today that its Chief Executive Officer, Elias Vamvakas, will participate in the BTIG Emerging Technologies in Healthcare Diagnostics Symposium on Tuesday, September 30, 2014 at the Benjamin Hotel in New York City. TEAR: 2.15 (+0.03), TLB.TO: 2.64 (unch)
Study Demonstrates Hyperosmolarity of the Ocular Surface May Impact Cataract Surgery Planning
GlobeNewswire - Mon Sep 15, 3:39PM CDT
TearLab Corporation (Nasdaq:TEAR) (TSX:TLB) ("TearLab" or the "Company"
announced that preliminary results of the TearLab Cataract Study were presented today at the XXXIII Congress of the European Society of Cataract and Refractive Surgeons ("ESCRS" . TEAR: 2.15 (+0.03), TLB.TO: 2.64 (unch)
TearLab to Participate in Craig-Hallum's 5th Annual Alpha Select Conference
GlobeNewswire - Thu Sep 11, 7:30AM CDT
TearLab Corporation (Nasdaq:TEAR) (TSX:TLB) ("TearLab" or the "Company"
announced today that its Chief Executive Officer, Elias Vamvakas, will present an update on the Company's business at the 5th Annual Craig-Hallum Alpha Select Conference on Thursday, September 18, 2014 at 2:50 p.m. Eastern Time at the Convene Conference Center in New York City. TEAR: 2.15 (+0.03), TLB.TO: 2.64 (unch)
TearLab Reports Interim Results From Multi-Center DED Prevalence Study in the UK
GlobeNewswire - Thu Sep 04, 7:36AM CDT
TearLab Corporation (Nasdaq:TEAR) (TSX:TLB) ("TearLab" or the "Company"
today announced interim results of a multi-center dry eye disease ("DED" prevalence study being carried out in the United Kingdom at four National Health Service ("NHS" hospitals. TEAR: 2.15 (+0.03), TLB.TO: 2.64 (unch)
TearLab to Host Analyst and Investor Day
GlobeNewswire - Thu Aug 14, 10:59AM CDT
TearLab Corporation (Nasdaq:TEAR) (TSX:TLB) ("TearLab" or the "Company"
announced today that it will host an "Analyst and Investor Day" in San Diego, CA on Tuesday, September 23, 2014. The event will be held at the Company's offices at 9980 Huennekens St. from 10:00am to 4:00pm Pacific Time. TEAR: 2.15 (+0.03), TLB.TO: 2.64 (unch)
TearLab to Participate in the Canaccord Genuity 34th Annual Growth Conference
GlobeNewswire - Mon Aug 11, 7:30AM CDT
TearLab Corporation (Nasdaq:TEAR) (TSX:TLB) ("TearLab" or the "Company"
announced today that its President & COO, Seph Jensen, will present an update on the Company's business at the Canaccord Genuity 34th Annual Growth Conference on Thursday, August 14, 2014 at 3:30 p.m. Eastern Time. The conference will be held at the InterContinental Boston Hotel in Boston, MA. TEAR: 2.15 (+0.03), TLB.TO: 2.64 (unch)
TearLab Corporation Reports Q2-14 Financial Results and Adjusts 2014 Revenue Guidance
GlobeNewswire - Thu Aug 07, 3:43PM CDT
TearLab Corporation (Nasdaq:TEAR) (TSX:TLB) ("TearLab" or the "Company"
today reported its consolidated financial results for the second quarter ended June 30, 2014. All dollar amounts are expressed in U.S. currency and results are reported in accordance with United States generally accepted accounting principles. TEAR: 2.15 (+0.03), TLB.TO: 2.64 (unch)
